Severe purpuric xerotic dermatitis associated with gefitinib therapy.
Sheen
Yi-Shuan
YS
Hsiao
Cheng-Hsiang
CH
Chu
Chia-Yu
CY
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D004890:Erythema / Q000139:chemically induced; D005260:Female; D000077156:Gefitinib; D006801:Humans; D007866:Leg; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D011693:Purpura / Q000139:chemically induced* / Q000473:pathology; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib